Katharine Knobil - 08 Dec 2021 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Issuer symbol
MRKR
Transactions as of
08 Dec 2021
Net transactions value
$0
Form type
4
Filing time
09 Dec 2021, 16:20:48 UTC
Previous filing
15 Jun 2021
Next filing
11 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 08 Dec 2021 Common Stock 125,000 $1.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over a three-year period commencing on January 8, 2022, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.